Prizvalve® Transcatheter Valve-in-Valve Implantation Exploratory Study

NCT05652062 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-11-18

No results posted yet for this study

Summary

The primary purpose of this clinical trial is to evaluate the efficacy and safety of the transcatheter aortic valve system in the treatment of patients with failing bioprosthetic valve

Conditions

  • Failing Bioprosthetic Valve

Interventions

DEVICE

Prizvalve® system

Transcatheter valve-in-valve replacement

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Shanghai NewMed Medical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-02
Primary Completion
2024-06-30
Completion
2024-06-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05652062 on ClinicalTrials.gov